ALNYLAM PHARMACE.DL-,0001 earnings per share and revenue

DUL earnings per share for the last quarter are -0.63 EUR whereas the estimation was -0.57 EUR which accounts for -9.78% surprise. Company revenue for the same period amounts to 572.99 M EUR despite the estimated figure of 562.78 M EUR. Estimated earnings per share for the next quarter are -0.85 EUR, and revenue is expected to reach 542.67 M EUR. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.